JOBKOREA

바이오의약품 개발 전문기업인 (주)팬젠은 치료용 단백질 의약품(바이오시밀러)개발과 생산을 하는 기업입니다.

PanGen is a leading biotechnology company based in South Korea in developing animal cell lines (particularly Chinese Hamster Ovary cells) and in production of proteins or antibodies from those cells. We would like to support the science community to save time and money by meeting their needs in animal cell technology.

PanGen has developed novel CHO cell expression systems that confer the overall efficiency of manipulation to cut down the conventional time and costs to handle the recombinant gene expression in animal cells. The combination of the patent pending technologies and well-trained researchers has made PanGen one of the leading companies in CHO cell technology. We produce proteins or cell lines for industry, academic, and governmental organizations for use in high-throughput screening, in vivo studies, diagnostics, research reagents, and the therapeutic purposes.

PanGen sees unique opportunities in the field of animal cell technologies that demand faster and cheaper ways to obtain proteins or antibodies for therapy or research. PanGen has entered into several partnership agreements with respectable multinational companies resulting in milestone and royalty payments.